A checkpoint regulates the rate of progression through S phase in S. cerevisiae in Response to DNA damage  by Paulovich, Amanda G & Hartwell, Leland H
Cell, Vol. 82, 841-847, September 8, 1995, Copyright © 1995 by Cell Press 
A Checkpoint Regulates the Rate of Progression 
through S Phase in S. cerevisiae 
in Response to DNA Damage 
Amanda G. Paulovich and Leland H. Hartwell 
University of Washington 
Department of Genetics 
Seattle, Washington 98195 
Summary 
We demonstrate that in S. cerevisiae the rate of ongo- 
ing S phase is slowed when the DNA is subjected to 
alkylation. Slowing of replication is dependent on the 
MEC1 and RAD53 genes, indicating that lesions alone 
do not slow replication in vivo and that the slowing is 
an active process. While it has been shown that a 
MEC1- and RAD53-dependent checkpoint responds to 
blocked replication or DNA damage by inhibiting the 
onset of mitosis, we demonstrate that this checkpoint 
must also have an additional target within S phase that 
controls replication rate. MEC1 is a homoiog of the 
human A TM gene, which is mutated in ataxia telangiec- 
tasia (AT) patients. Like mecl yeast, AT cells are char- 
acterized by damage-resistant DNA synthesis, high- 
lighting the congruence of the yeast and mammalian 
systems. 
Introduction 
Cells have regulatory checkpoints that control cell cycle 
progression in response to DNA damage (Hartwell and 
Weinert, 1989; Murray, 1992, 1993). For example, cells 
experiencing DNA breaks arrest in the G2 phase of the 
cell cycle so that broken chromosomes can be repaired 
before being segregated (Busse et al., 1978; Weinert and 
Hartwell, 1988). In Saccharomyces cerevisiae, this arrest 
is dependent on the functions of the RAD9, RAD17, RAD24, 
MECl lESR1, RAD531MEC21SAD11SPK1, and MEC3 gene 
products (Weinert and Hartwell, 1993; Weinert et al., 1994). 
Likewise, when yeast cells in the G1 phase are subjected 
to ultraviolet irradiation, they delay the onset of S phase 
(Siede et al., 1993). In S. cerevisiae, the RAD9, RAD24, 
and RAD53 gene products are required for this delay (Allen 
et al., 1994; Siede et al., 1993, 1994), which is presumed 
to allow time for repair of the damaged template prior to 
its replication. Yeast cells also have a checkpoint hat pre- 
vents the onset of mitosis when DNA replication is blocked 
with hydroxyurea (HU) or the cdc8 mutation, and this con- 
trol is dependent on the function of the MEC1 and RAD53 
gene products (Allen et al., 1994; Weinert et al., 1994). 
The biochemical basis for the involvement of this group 
of gene products in the control of these three cell cycle 
transitions is not understood. 
Ataxia telangiectasia (AT) is a fatal genetic disease of 
childhood characterized by autosomal recessive inheri- 
tance, immunological deficiencies, disabling ataxia asso- 
ciated with progressive cerebellar Purkinje cell death, and 
a high incidence of malignancies (reviewed by Friedberg 
et al., 1995). Heterozygotes also have an increased inci- 
dence of cancer (Swift et al., 1987, 1991), which is of great 
importance, since the conservative stimate is that 1% of 
the United States population are carriers (Swift et al., 
1986). Cells from AT patients are hypersensitive to ionizing 
radiation (IR) and are defective in both G1 (Kastan et al., 
1992) and G2 (Zampetti-Bosseler and Scott, 1981 ; Paules 
et al., 1995) cell cycle checkpoints following exposure to 
IR. A recent report demonstrates that AT results from a 
mutation in the A TM (AT mutated) gene, and that this gene 
is a homolog of the budding yeast MEC1 checkpoint gene 
(Savitsky et al., 1995). 
DNA replication is inhibited when mammalian cells are 
subjected to DNA damage (Larner et al., 1994; Painter and 
Young, 1980; Young and Painter, 1989). This inhibition is 
due not only to a decrease in the initiation of replicons, but 
also to a decrease in the rate of elongation of preexisting 
nascent strands (Lamer et al., 1994; Painter and Young, 
1980). AT cells fail to inhibit both new initiation events 
and elongation in response to DNA damage (Painter and 
Young, 1980), in addition to their defects in the G1 and 
G2 checkpoints. These data led to the suggestion that AT 
cells lack a factor or process that in normal cells delays 
replication after irradiation (Painter and Young, 1980). 
While mutants defective in G1 and G2 checkpoints have 
been described in other systems (Hartwell and Weinert, 
1989; Murray, 1992), no parallel has been reported for the 
defect in control within S phase that AT cells demonstrate. 
In this report, we show that in S. cerevisiae the rate of 
ongoing DNA replication is regulated in response to DNA 
damage, and that this regulation is dependent on the 
MEC1 and RAD53 gene products. Hence, yeast cells mu- 
tant for an ATM homolog, MEC1, are defective in both the 
G2 checkpoint (Weinert et al., 1994) and S phase regula- 
tion, as are AT cells. This suggests that the relationship 
between these two genes may extend beyond sequence 
similarity, and that MEC1 may be a functional homolog 
of A TM. 
It has been previously shown that MEC1 and RAD53 
are necessary to inhibit the onset of mitosis in response 
to DNA damage or in response to incomplete replication 
(Allen et al., 1994; Weinert et al., 1994). Our findings ex- 
tend previous results by demonstrating that this check- 
point also responds to DNA damage in S phase and must 
have an additional target within S phase that controls the 
rate of ongoing S phase. We suggest that this target may 
be the replication apparatus and that repair and replication 
may be coupled, similar to the coupling of repair to tran- 
scription (Leadon and Lawrence, 1992; Selby and Sancar, 
1993; Smerdon and Thoma, 1990; Sweder and Hanawalt, 
1992). 
Results 
Wild-Type Yeast Cells Replicate Slowly 
in Response to DNA Damage 
To assess the effects of DNA damage on replication in 
vivo, we have analyzed cells in which the DNA is being 
damaged and repaired continuously. When a Iogarithmi- 
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Figure 1. Effects of Continuous Exposure to 0.015% MMS on an 
Asynchronous Population of Yeast Cells 
(a) Viability of wild-type cells in the presence or absence of 0.015% 
MMS. 
(b) Inhibition of cell division by 0.015% MMS. 
(c) Large-budded arrest of MMS-treated cells. 
All curves in (a), (b), and (c) are the average of two independent experi- 
ments. 
(d) Flow cytometry showing slowing of S phase in response to MMS. 
Shaded histograms represent the cell cycle distribution of the asyn- 
chronous culture, prior to addition f MMS. Overlaid histograms repre- 
sent the cell cycle distribution at various times after addition of MMS. 
cally growing population of wild-type yeast cells is exposed 
to a sublethal dose (Figure la) of the monofunctional lkyl- 
ating agent methyl methanesulfonate (MMS), the distribu- 
tion of cells in the cell cycle is dramatically altered. Cell 
division is inhibited within one cell cycle time (Figure 1 b), 
and cells accumulate with a large-budded morphology 
Figure 2. Inhibition of the Slow S Phase by c{ Factor and by HU 
Flow cytometry profiles of wild-type cells synchronized inG1 and then 
incubated for 30 min under various conditions. Shaded histograms 
represent the cell cycle distribution of the asynchronous starting cul- 
ture. Overlaid histograms represent the cell cycle distribution after 30 
min of release or no release from (z factor under various conditions. 
(a) a factor-arrested cells, prior to elease. 
(b) Cells released from a-factor arrest inthe absence of MMS. 
(c) Cells released from mfactor arrest in he presence of 0.015% M MS. 
(d) Cells held in (~ factor in the presence of 0.015% MMS. 
(e) Cells released from s-factor arrest in he presence of 0.015% MMS 
and 0.5 M HU. 
(Figure lc), indicating that they have passed "start." Con- 
comitant with the large-budded arrest, cells appear to ac- 
cumulate with an S phase content of DNA, and replication 
appears to continue at a slower than normal rate in re- 
sponse to the damage (Figure ld). Replication in the ab- 
sence of MMS takes fewer than 30 min (see below), 
whereas replication in the presence of 0.015% M MS takes 
approximately 3-4 hr, after which cells accumulate in G2 
(Figure ld). 
We repeated this experiment with cells synchronized in 
the G1 phase and released into the cell cycle in either the 
presence or the absence of MMS (see Figure 4a). Once 
again, wild-type cells experiencing DNA damage appear 
to replicate their DNA more slowly than control cells. Cells 
complete replication within 30 min in the absence of MMS, 
whereas cells replicating in the presence of 0.033% MMS 
have still not completed replication 180 rain after release 
from g-factor arrest (see Figure 4a). Note that different 
concentrations of MMS appear to produce a similar degree 
of slowing of DNA replication (compare Figu re 1 d, 0.015% 
MMS and Figure 4a, 0.033% MMS). This is most likely 
due to the fact that cells would experience more lesions 
in the asynchrony experiment (Figure 1) than in the syn- 
chrony experiment (see Figure 4) for the same dose of 
MMS. This occurs because the MMS is present continu- 
ously throughout hese experiments. Unlike cells in the 
synchrony experiment (see Figure 4a), the majority of cells 
in the asynchronous culture spend at least 1 hr in MMS 
before entering S phase (Figure ld). During this time, le- 
sions may continue to accumulate, and the subsequent 
slowing of S phase is enhanced accordingly. In fact, if the 
dose-response curve is compared between two syn- 
chrony experiments, it is clear that the degree to which 
S phase is prolonged is proportional to the dose of MMS 
delivered. For example, compare Figure 4a with Figure 
2c. This slowing of S phase is not specific for alkylation 
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damage, as we have observed a similar effect in response 
to exposure to ultraviolet irradiation as well as 4-nitro- 
quinoline-l-oxide (A. G. P., B. U. Margulies, and L. H. H., 
unpublished data). 
Yeast flow cytometry peak positions can be affected by 
cell size and mitochondrial DNA content. An example of 
this can be seen in Figure 2b, where the histogram of 
G2 phase cells that have previously been held in G1 has 
shifted slightly to the right. Therefore, to confirm that the 
peak shifting we observe in our flow cytometry histograms 
is a reflection of chromosomal DNA synthesis and not an 
artifact of prolonged cell cycle arrest at the G1 checkpoint 
or of MMS treatment, we performed the following three 
controls. First, if the shifting of the peak is due to nuclear 
DNA synthesis, it should be inhibited by the continued 
presence of the mating pheromone ~ factor, which induces 
cells to arrest in the G1 phase, yet allows cells to continue 
to grow and to synthesize mitochondrial DNA (Petes and 
Fangman, 1973). Second, it should also be inhibited by 
the addition of the DNA replication inhibitor HU. We syn- 
chronized wild-type cells in G1 with ~ factor (Figure 2a) 
and then either released them into the cell cycle in the 
absence of MMS (Figure 2b), released them in the pres- 
ence of MMS (Figure 2c), held them in ~ factor in the 
presence of MMS (Figure 2d), or released them from 
factor in the presence of MMS and HU (Figure 2e). Indeed, 
histograms obtained from cells either held in ~ factor in 
MMS (Figure 2d) or released from ~ factor into MMS and 
HU (Figure 2e) do not demonstrate the peak shifting ob- 
served when cells are released in the absence of HU (Fig- 
ure 2c). 
Third, if MMS-treated cells are replicating chromosomal 
DNA, then the ability of these cells to survive X-ray damage 
should progressively increase as the genome undergoes 
replication during the damage-induced slow S phase. 
X-rays induce double-strand DNA breaks, which are re- 
paired in yeast by homologous recombination (Resnick 
and Martin, 1976; Szostak et al., 1983). G1 haploid cells 
lack sister chromatids and therefore are much more sensi- 
tive to killing by X-rays than G2 cells (Brunborg and Wil- 
liamson, 1978; Brunborg et al., 1980). This can be seen 
by comparing the X-ray kill curves of cells arrested in either 
factor (G1) or methyl benzimidazol-2-yl carbamate 
(MBC) (G2) (Figure 3). Concomitant with the apparent in- 
crease in DNA content (see Figure 2c), MMS-treated cells 
become progressively more resistant o X-rays (Figure 3). 
By 20 min after release from a factor in the absence of 
MMS, cells have already completed replication and are 
as resistant to X-rays as MBC-arrested G2 phase cells. 
In contrast, cells released from a factor into 0.015% MMS 
for 20 min have not yet attained the G2 level of X-ray 
resistance, consistent with their replicating slowly. How- 
ever, if the MMS-treated cells are allowed to complete 
their slow S phase (flow cytometry data not shown), they 
become as resistant o X-irradiation as cells synchronized 
in the G2 phase with MBC (Figure 3, 90 min time point). 
Cells held in ~ factor and treated with MMS do not become 
more resistant to X-rays (data not shown), ruling out the 
possibility that M MS treatment in the absence of D NA repli- 
cation could explain the increased resistance of these 
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Figure 3. SIowAcquisitionofG2X-RayResistancebyWild-TypeCells 
Released from a Factor into 0.015% MMS 
Cells were synchronized in the G1 phase and released into the cell 
cycle into either the presence or absence of 0.015% MMS. At various 
times after release, samples were removed for determination fX-ray 
resistance. All curves are the average of at least two independent 
experiments. 
cells, and unequivocally demonstrating that these wild- 
type cells have completed chromosomal replication. 
On the basis of these three controls, we conclude that 
the flow cytometry profiles we obtain from MMS-treated 
cells accurately reflect nuclear DNA content. Furthermore, 
we conclude that beyond the G1-S phase transition, cells 
experiencing MMS-induced damage are slowed in their 
rate of progression throughout he S phase. 
Slowing of Replication in Response to DNA Damage 
Is an Active Process That Is Dependent on the 
MEC1 and RAD53 Gene Products 
Slowing of replication in the presence of DNA damage 
could be explained by in vitro observations that a DNA 
polymerase is blocked by 3-methyladenine (Boiteux et al., 
1984), one adduct induced by MMS (Singer and Grun- 
berger, 1983). An alternative explanation for the slow S 
phase is that cells have a genetic control mechanism that 
regulates progress through S phase when the DNA is be- 
ing damaged, as has been suggested by previous work 
done on cells from AT patients (Painter and Young, 1980). 
If S phase progression is genetically controlled, it should 
be possible to identify mutations that inactivate 'the control. 
Cells carrying these mutations might be sensitive to alkyl- 
ation damage and might progress as rapidly through S 
phase in the presence as in the absence of damage. Since 
it had already been demonstrated that RAD53 is necessary 
for DNA damage-induced cell cycle regulation at the G1-S 
phase transition (Allen et al., 1994) and that both MEC1 
and RAD53 are necessary for regulation at the S-M phase 
(Allen et al., 1994; Weinert et al., 1994) and G2-M phase 
(Weinert et al., 1994) transitions, we tested whether these 
same genes were also necessary for the slowing of S 
phase progression in response to damage. 
We synchronized congenic wild-type, mecl, and rad53 
cells in the G1 phase by using c~ factor and then released 
each strain into the cell cycle in either the presence or 
the absence of 0.033% MMS (Figure 4). MMS treatment 
causes a brief delay in G1-S transition in all three strains 
Cell 
844 
MMS: 
0 min. 
15 min. 
a 
WT 
- + 
bmecl Crad53 
- - I -  - 4 -  
30 min. 
55 min. 
75 min. 
120 min. 
180 min. 
Figure 4. Dependence of S Phase Regulation on the MEC1 and 
RAD53 Checkpoint Genes 
Cells were synchronized in G1 and released in either the presence 
or the absence of 0.033% MMS. Shaded histograms represent the 
cell cycle distribution of the asynchronous culture, prior to (z-factor 
treatment. Overlaid histograms represent the cell cycle distribution 
after elease from (z factor into _+ 0.033% MMS for the indicated times. 
(a) wild-type, viability 29% at 120 min. 
(b) mecl, viability <0.010/0 at 120 min. 
(c) rad53, viability <0.01% at 120 rain. 
All viabilities are the average of two independent experiments. 
(see also Figures lc  and ld). However, in striking contrast 
with the behavior of wild-type cells (Figure 4a), once mec 1 
(Figure 4b) and rad53 (Figure 4c) mutants leave G1, they 
progress rapidly through S phase regardless of whether 
or not MMS is present. (Note that tad53 cells release poorly 
from (~ factor even in the absence of MMS. This may be 
related to the slow growth and low plating efficiency of 
this mutant [A. G. P. and L. H. H., unpublished data].) 
Moreover, failure to control replication rate in MMS is asso- 
ciated with sensitivity to this agent. After 2 hr in MMS, 
wild-type cells are 29% viable, whereas both mutants are 
<0.01% viable. On the basis of the rapid rate of replication 
of mecl  and rad53 mutants in the presence of MMS, we 
conclude that wild-type cells regulate th rate of S phase 
progression in response to alkylation damage, and that 
this regulation is dependent on the MEC1 and RAD53 
genes. Loss of S phase regulation is not a general charac- 
teristic of MMS-sensitive mutants. For example, a rad51,J 
mutant is sensitive to MMS but replicates DNA at the slow, 
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Figure 5. Two Models for Slow S Phase in Response to DNA Damage 
(a) The S phase regulation described in this report could result from 
a checkpoint that acts locally at replication forks to couple repair of 
the damaged template with its replication. In this model, MEC1 and 
RAD53 could stall the advancing replication fork until esions (aster- 
isks) are repaired. 
(b) Alternatively, replication over or a ound lesions could slow S phase 
and be dependent on MEC1 and RAD53. Hence, rather than controlling 
entry of lesions into replication forks, MEC1 and RAD53 could be nec- 
essary for viably replicating over l sions. 
wild-type rate in the presence of the MMS (A. G. P., B. M. 
Garvik, and L. H. H., unpublished data). 
Discussion 
Our finding that mecl  and rad53 mutants replicate dam- 
aged and undamaged DNA at comparable rates rules out 
a model in which lesions alone are able to slow replication 
and demonstrates that the slowing of S phase is an active 
process that fits the empirical definition of a checkpoint 
(Hartwell and Weinert, 1989). It is possible that this S 
phase regulation is the result of a delay in late replication 
origin firing within S phase, a decrease in the number of 
origins used, a decrease in the rate of elongation of na- 
scent DNA strands, or some combination of the above. 
Our results cannot distinguish among these possibilities. 
Nonetheless, it is striking that wild-type cells maintain high 
viability despite he constant presence of M M S throughout 
the entire slow S phase (Figure la). A mechanism that 
delays only initiation would not explain how cells survive 
continuous exposure to a DNA-damaging agent through- 
out S phase, since DNA replicons must be receiving dam- 
age after initiation and during elongation. 
One possible explanation for the high viability of wild- 
type cells is that there could be a cis-acting control at 
replication forks that couples elongation of the nascent 
strand with repair of damage in the template strand (Figu re 
5A). The well-established coupling of repair to transcrip- 
tion (Leadon and Lawrence, 1992; Selby and Sancar, 
1993; Smerdon and Thoma, 1990; Sweder and Hanawalt, 
1992) provides a strong precedent for coupling passage 
of a polymerase with repair of a damaged template. Yeast 
DNA polymerase ~ is necessary for induction of repair 
machinery in response to DNA damage (Navas et al., 
1995), demonstrating that this essential polymerase plays 
a role in signaling the presence of damage, consistent 
with a model of replication-repair coupling. Interestingly, 
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the DNA damage- induc ib le  CDK inhibitor p21 inhibits rep- 
lication elongation in vitro by interfering with proliferating 
cell nuclear antigen, or PCNA (Waga et al., 1994), a com- 
ponent of the replication apparatus, providing a possible 
molecular mechanism by which the checkpoint that regu- 
lates replication of damaged templates might sta!l replica- 
tion until repair is completed. 
A second possible explanation for the slow replication 
and high viabil ity of wild-type cells despite continuous al- 
kylation is as follows. Despite the fact that many lesions 
block DNA polymerases in vitro, cells are able to replicate 
in the presence of lesions (Kadyk and Hartwell, 1993; re- 
viewed by Naegeli, 1994). This is bel ieved to be possible 
because in vivo polymerase is able either to bypass lesions 
or to replicate across lesions (reviewed by Naegeli, 1994), 
resulting in either the induction of sister chromatid ex- 
changes or mutation, respectively. Such a mode of bypass 
synthesis could depend on MEC1 and RAD53 and result 
in slow replication across lesions (Figure 5B). This could 
explain the rapid rate of S phase in these mutants in MMS. 
It will be of interest to measure induced mutation and sister 
chromatid exchange rates in these mutants. 
In S. cerevisiae, an S -M checkpoint prevents the onset 
of mitosis when replication forks are stalled by HU or the 
cdc8 mutation (Allen et al., 1994; Weinert et al., 1994), 
and this control is dependent on MEC1 and RAD53 (Allen 
et al., 1994; Weinert et al., 1994). It has been assumed 
that the signal for this checkpoint is stalled replication forks 
and that the target is some component of the mitotic appa- 
ratus. Our results extend these previous observations by 
demonstrating that control within S phase responds to 
DNA damage as well and must also target some compo- 
nent of the replication machinery to produce the slowing 
of S phase. Surprisingly, the fission yeast hus l  mutation, 
which confers HU sensitivity and a defect in S -M control, 
causes lethality in HU prior to the onset of mitosis, leading 
to the suggestion that this gene may also have a function 
within S phase (Enoch et al., 1992). A defect in S phase 
regulation may explain this result, and it will be interesting 
to test whether the hus l  mutant is proficient at S phase 
control in response to damage. 
Patients with the cancer-prone disorder AT are mutant 
for the ATM gene, a homolog of the yeast MEC1 gene 
(Savitsky et al., 1995). AT cells are defective in the G1 
checkpoint (Kastan et al., 1992), in the G2 checkpoint 
(Zampetti-Bosseler and Scott, 1981; Paules et al., 1995), 
and in inhibiting replication in response to DNA damage 
(Painter and Young, 1980). The mecl  mutant had pre- 
viously been shown to be defective in the G2 checkpoint 
(Weinert et al., 1994), and we demonstrate that it is also 
defective in regulating S phase in response to alkylation 
damage. (The role of the MEC1 gene in the G 1 checkpoint 
has not been examined, but it seems likely that it will be 
involved, given that all three of the six checkpoint mutants 
that have been tested are necessary for the G1 check- 
point.) On the basis of the phenotypic similarities of AT 
cells and mac1 mutants, we suggest that the relationship 
between these two genes may extend beyond sequence 
similarity and suggest that MEC1 is a functional homolog 
of ATM. It will be of interest to determine whether MEC1 
can suppress the damage-resistant DNA synthesis of AT 
cells. 
In this issue of Cell, Greenwell  et al. (1995) report that 
mutation of the S. cerevisiae TEL1 gene, a second ATM 
homolog, causes shortening of telomeres. A short telo- 
mere phenotype has also been reported for AT cells (Pan- 
dita et al., 1995). While the effect of the te l l  mutation on 
mitotic checkpoints has not yet been examined, the wild- 
type sensitivity of this mutant to ionizing radiation suggests 
that its checkpoints are functional (Greenwell et al., 1995). 
Conversely, mecl  mutants have normal telomere length 
(Greenwell et al., 1995) but are defective in S and G2 
checkpoints (Weinert et al., 1994), as are AT cells. Given 
these parallels, the genetic interaction between MEC1 and 
TEL1, also reported in this issue of Cell (Morrow et al., 
1995), is intriguing, and the human ATM gene may have 
more than one functional homolog in S. cerevisiae. 
Experimental Procedures 
Yeast Strains 
Yeast strains used in this study were from the A364a background: 
wild type, 7830-2-4a, Mata ura3 leu2 trpl his3. Mutants were provided 
by T. Weinert and D. Lydall: DLY264, Mata ura3 leu2 trpl his3 mac2-1:: 
URA3, and DLY285, Mata ura3 leu2 trpl his3 mecl-l::HIS3. 
MMS Asynchrony Experiment 
Cells (1.1 x 109) were harvested from a log phase culture grown over- 
night at 30°C in YM-1 plus 2% glucose. Cells were resuspended in 
211 ml of YM-1 plus 2% glucose, and 11 ml was removed for (t = 0) 
cell cycle analysis and viability assessment. The remaining 200 ml 
was split in half, and one half was treated with 300 pl of 5% MMS in 
YM-I. The cultures were incubated at 30°C, and at various times 
thereafter, 11 ml samples were again removed for viability assessment 
and cell cycle analysis. 
Viability Assessment 
Cell concentration was determined by using a Coulter Channelizer. 
The number of viable cells/ml was determined by plating serial dilu- 
tions of cultures onto C plates and scoring the number of colony- 
forming units (CFU) after 2-3 days at 30°C. Viability was calculated 
as CFU per ml divided by the total number of cells per ml. 
Flow Cytometry 
For flow cytometry, 10 ml samples were harvested, and cells were 
fixed in 70% ethanol for 12-24 hr at 4°C. Samples were then washed 
once with 5 ml of 50 mM sodium citrate (pH 7.5) and resuspended in 
1 ml of 50 mM sodium citrate. Cell concentration was determined by 
using a Coulter Channelizer, 8 x 10 ~ cells were transfe, rred to a new 
tube, and the total volume was adjusted to 1 ml with 50 mM sodium 
citrate. To each sample, 25 ~.1 of 10 mg/ml RNase A was added, and 
after a 1 hr incubation at 50°C, 50 ~.1 of 20 mg/ml proteinase K was 
added. The incubation was continued an additional 1 hr at 50°C, after 
which 1 ml of 50 mM sodium citrate containing 16 pg/ml propidium 
iodide was added. Samples were incubated in the dark for 12-48 hr 
at 4°C and analyzed with a Becton Dickinson fluorescence-activated 
cell analyzer. For each histogram, 15,000 cells were analyzed. 
HU Inhibition of S Phase 
Cells (2.2 x 109) were harvested from a log phase culture grown over- 
night in YM-1 plus 2% glucose, resuspended at 5 x 106 cells/ml in 
YM-1 plus 2% glucose plus 3 pM c( factor, and incubated for 2 hr at 
30°C. The synchronous culture was split into four parts: one part was 
treated with 0.5 M HU, one with 0.015% MMS (final concentration), 
one with 0.5 M HU plus 0.015% MMS (final concentration),'and one 
was left untreated. All four parts were incubated for an additional 30 
min at 30°C to allow the MMS and HU to enter the cells. The cultures 
were then released into the cell cycle by harvesting them and resus- 
pending them in YM-1 plus 2% glucose plus 0.1 mg/ml pronase ± 
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0.015% MMS -+ 0.5 M HU, as indicated above. The cultures were 
incubated an additional 30 rain at 30°C and subsequently fixed for 
flow cytometry. 
~z Factor Inhibition of S Phase 
Cells (2.2 x 109) were harvested from a log phase culture grown over- 
night in YM-1 plus 2% glucose, resuspended at 5 x 10 B cells/ml in 
YM-1 plus 2% glucose plus 3 I~M a factor, and incubated for 2 hr at 
30°C to allow time for the cells to arrest in G 1. The synch ronous culture 
was split in half, one half was treated with 633 p_l of 5% MMS in YM-1, 
and the incubation was continued at 30°C for an additional 30 min to 
allow time for the MMS to enter the cells. The cultures were again 
split in half, and one half was treated with an additional 5 I~M ,z factor 
(final concentration) and incubated a further 30 rain before cell cycle 
analysis. The second half was harvested by centrifugation, released 
from ~-factor arrest by resuspension in 100 ml of YM-1 plus 2% glucose 
plus 0.1 mg/ml pronase, _+ 0.015% MMS, and incubated an additional 
30 rain at 30°C before cell cycle analysis. 
MBC Arrest 
Cells (1.1 x 108) were harvested from a log phase culture grown over- 
night at 30°C in YM-1 plus 2% glucose, Cells were resuspended in 
21 ml of medium, and 10 ml was removed and processed for flow 
cytometry. To the remaining 11 ml, 110 tll of 20 mg/ml MBC in DMSO 
was added. The culture was incubated for 2.5 hr at 30°C, after which 
10 mi was again removed and processed for flow cytometry. 
X-Ray Experiment 
Cells (5.3 x 108) were harvested from a log phase culture grown over- 
night at 30°C in YM-1 plus 2% glucose. Cells were resuspended in 
104 ml of medium, 11 ml was removed for cell cycle analysis and 
viability assessment, and the remainder was treated with 3 pM 
factor (final concentration) for 2 hr at 30°C. The culture was split in 
half, one half was treated with 0.015% MMS final concentration, and 
the cultures were incubated an additional 30 min at 30°C. Finally, the 
cultures were harvested and released into the cell cycle by resuspen- 
sion in 30 ml of YM-1 plus 2% glucose plus 0.1 mg/ml pronase, _ 
0.0150/o MMS (final concentration). The incubation was continued at 
30°C, and samples were withdrawn after 20 and 90 min for determina- 
tion of X-ray sensitivity. X-ray kill curves were generated by plating 
serial dilutions onto C plates and irradiating them with varying doses 
of X-rays delivered by a Machlett OEG 60 X-ray tube operated at 50 
kV and 20 mA, delivering a dose rate of 106 rad/s. Viability was calcu- 
lated as the viable cell concentration at a given dose of X-rays divided 
by the viable cell concentration of unirradiated cells. 
MMS Synchrony Experiment 
Cells (1 x 108) were harvested from log phase cultures grown over- 
night at 30°C in YM-1 medium plus 2% glucose. Cells were resus- 
pended in 210 ml of YM-1 plus 2% glucose, 10 ml was removed for 
flow cytometry, and the remainder of the culture was synchronized in 
the G1 phase by the addition of 3 pM ~ factor (final concentration). 
After 2 hr of incubation at 30°C, the culture was split in half, and one 
half was treated with 667 I~1 of 5% MMS in YM-1. The incubation was 
continued at 30°C for an additional 30 min, after which 10 ml was 
removed (t = 0) for cell cycle analysis. The cultures were harvested 
and released into the cell cycle by resuspension in 100 ml of YM-1 
plus 2% glucose plus 0.1 mg/ml pronase, _+ 0.033% MMS final con- 
centration. At the indicated times after release, samples were removed 
for viability assessment, cell cycle analysis, or both. 
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